Optimization of an Experimental Vaccine To Prevent Escherichia

A Customized Bayesian Algorithm to Optimize Enzyme-Catalyzed Reactions

Full article: Applying high throughput and comprehensive immunoinformatics approaches to design a trivalent subunit vaccine for induction of immune response against emerging human coronaviruses SARS-CoV, MERS-CoV and SARS-CoV-2

Vaccine-induced COVID-19 mimicry syndrome

Frontiers The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine

Intranasal COVID-19 vaccines: From bench to bed - eBioMedicine

Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity, Microbial Cell Factories

A mass spectrometry guided approach for the identification of novel vaccine candidates in gram-negative pathogens

Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera - eBioMedicine

mRNA vaccines for COVID-19: what, why and how

PDF) Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments

Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity, Microbial Cell Factories

Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use - Cytotherapy